Uni-Bio Science Group Limited (HKG:0690)
Hong Kong · Delayed Price · Currency is HKD
0.0940
+0.0030 (3.30%)
May 7, 2026, 3:19 PM HKT
Revenue by Segment
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Chemical Pharmaceutical Products | 199.76M | 249.62M | 257.87M | 232.49M | 146.67M | | | | | |
Chemical Pharmaceutical Products Growth | -19.97% | -3.20% | 10.91% | 58.52% | 263.89% | | | | | |
Biological Pharmaceutical Products | 386.45M | 303.36M | 226.85M | 207.82M | 206.74M | | | | | |
Biological Pharmaceutical Products Growth | 27.39% | 33.73% | 9.16% | 0.52% | 22.71% | | | | | |
| 586.21M | 552.98M | 484.72M | 440.32M | 353.41M | | | | | |
| 6.01% | 14.08% | 10.08% | 24.59% | 69.27% | | | | | |
Revenue by Geography
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
The People's Republic of China (PRC) | 586.21M | 552.98M | 484.72M | 440.32M | 353.41M | | | | | |
The People's Republic of China (PRC) Growth | 6.01% | 14.08% | 10.08% | 24.59% | 69.27% | | | | | |
| 586.21M | 552.98M | 484.72M | 440.32M | 353.41M | | | | | |
| 6.01% | 14.08% | 10.08% | 24.59% | 69.27% | | | | | |
Source: S&P Global Market Intelligence.
